Piperazine ferulate prevents high-glucose-induced filtration barrier injury of glomerular endothelial cells.

Yang, Yong-Yu; Chen, Zhuo; Yang, Xi-Ding; Deng, Rong-Rong; Shi, Ling-Xing; Yao, Liang-Yuan; Xiang, Da-Xiong

Yang, Yong-Yu; Chen, Zhuo; Yang, Xi-Ding; Deng, Rong-Rong; Shi, Ling-Xing; Yao, Liang-Yuan; Xiang, Da-Xiong.

Afiliação

Yang YY; Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, P.R. China.
Chen Z; Hunan Provincial Engineering Research Central of Translational Medical and Innovative Drug, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, P.R. China.
Yang XD; Department of Geriatrics, The Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, P.R. China.
Deng RR; Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, P.R. China.
Shi LX; School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, Guangdong 510006, P.R. China.
Yao LY; Department of Pharmacology, Changsha Medical University, Changsha, Hunan 410219, P.R. China.
Xiang DX; Hunan Qianjin Xiangjiang Pharmaceutical Industry Co., Ltd., Zhuzhou, Hunan 412000, P.R. China.

Exp Ther Med ; 22(4): 1175, 2021 Oct.

Article em En | MEDLINE | ID: mdl-34504620

Palavras-chave

adenosine monophosphate-activated protein kinase; diabetic nephropathy; filtration barrier; glycocalyx; piperazine ferulate; tight junction

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Exp Ther Med Ano de publicação: 2021 Tipo de documento: Article